Actively Recruiting

Phase Not Applicable
Age: 16Years - 50Years
All Genders
NCT05290285

Amino Acids in Patients With Anorexia Nervosa: Double-blind Randomized Study Versus Placebo

Led by Villa Garda Hospital · Updated on 2025-09-05

92

Participants Needed

1

Research Sites

235 weeks

Total Duration

On this page

Sponsors

V

Villa Garda Hospital

Lead Sponsor

U

University of Milan

Collaborating Sponsor

AI-Summary

What this Trial Is About

Amino acids (AAs) are crucial for protein synthesis, in influencing nutritional status, as sources of vital elements (e.g., nucleotides, neurotransmitters) and as signal molecules for the modulation of gene expression and epigenetic mechanisms. Data on the role of amino acids in underweight patients with anorexia nervosa (AN) are unknown. This study aims to evaluate whether a blend of essential amino acids (EAA) could influence the change in lean body mass (LBM) in patients with AN during weight restoration, treated with intensive inpatient enhanced cognitive behavior therapy (CBT-E). A total of 92 patients will be randomized to EAA supplementation or placebo supplementation upon admission to inpatient treatment. LBM, but also body weight, specific and general psychopathology, impairment assessment will be assessed at baseline and after 13 weeks of treatment.

CONDITIONS

Official Title

Amino Acids in Patients With Anorexia Nervosa: Double-blind Randomized Study Versus Placebo

Who Can Participate

Age: 16Years - 50Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of anorexia nervosa
  • Age between 16 and 50 years
  • Written informed consent
Not Eligible

You will not qualify if you...

  • Schizophrenia or other psychotic disorders
  • Diagnosis of bulimia nervosa
  • Current and ongoing substance use disorder
  • Medical complications that could affect result interpretation, such as diseases causing weight loss
  • Physical treatments, including drugs, that could affect result interpretation, such as chemotherapy for cancer
  • Being pregnant or intending to become pregnant during treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Eating and Weight Disorders, Villa Garda Hospital

Garda, Italy, Italy, 37016

Actively Recruiting

Loading map...

Research Team

R

Riccardo Dalle Grave, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here